Trial intelligence / Profile preview

Symbicort in African American Patients With Asthma

NCT00419952Phase 3Completed

Sponsor
AstraZeneca
Start
Feb 2007
Primary completion
Nov 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Feb 2007; status: completed.

02

Drugs

budesonide
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00419952.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00419952.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call